NEW DELHI: Following Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech submitted a request to the central drug regulator on Monday for an emergency use authorization for its Covid-19 Covaxin vaccine, official sources said. Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council for …
Read More »
New Delhi: An investigation launched by the Comptroller General of Drugs of India (DCGI) into an alleged “serious adverse event” suffered by an Oxford COVID-19 The participant of the vaccine trial in Chennai found that it was not related to the injection he was given, official sources said. The DCGI …
Read More »
Despite low efficiency, it is the best bet for India Dr. Jameel, stating a simple fact there. These vaccines require very cold storage. Pfizer must be stored at -70 degrees Celsius, requires specialized containers, transportation, training and distribution. Moderna vaccine can be stored at -20 degrees Celsius and can be …
Read More »
A stroke of good luck from a dosing error will pave the way for AstraZeneca and the University of Oxford to submit their Covid-19 vaccine for regulatory approval. The British pharmacist said on Monday that the vaccine could be around 90% effective, when given as a half dose followed by …
Read More »
The global search for an effective coronavirus vaccine is still underway, as more than 57 million people have contracted the disease so far and more than 1.3 million have lost their lives from it. The pharmaceutical companies Pfizer and Moderna recently declared that their vaccine candidates have been successful in …
Read More »
The Oxford-AstraZeneca vaccine for coronavirus disease could be available to the general public between April and May next year and is likely to cost around ₹ 500-600 per dose, the executive director of the Serum Institute of India said on Thursday. , Adar Poonawalla, adding that he expects the long-awaited …
Read More »
Written by Prabha Raghavan | New Delhi | Updated: November 20, 2020 7:08:08 am The candidate, who is being manufactured by SII under an agreement with Oxford-AstraZeneca, is the pioneer in India’s own race to find a vaccine to defeat the novel coronavirus. (Photo of Fie) Serum Institute of India …
Read More »
A worker works at an overpass construction site amid smog in New Delhi. (Reuters) Consumer inflation rose again to pre-virus highs in October, and almost all broad categories except fuel saw prices rise. While the fourth quarter is likely to mark the peak of inflation, we have become more cautious …
Read More »
The world, eagerly awaiting a vaccine to beat the coronavirus disease (Covid-19), could turn the corner with the Oxford University candidate showing promising results. This could be a sign of relief for devastated economies and overworked healthcare systems in major nations battling the viral contagion that has claimed 1.15 million …
Read More »
AstraZeneca COVID-19 vaccine candidate testing will continue. (Figurative) Highlight The Brazilian health authority said a volunteer from a vaccine trial died The trial would have stopped if the volunteer had received the vaccine: Sources So far, 8,000 of the 10,000 planned volunteers have been recruited. Sao Paulo / Frankfurt: Brazilian …
Read More »